NEWS & MEDIA

PH News

Putting the PH in PHamily.

Welcome to PHA Canada’s news section. Here, you can read the latest pulmonary hypertension news, hear from patients, medical providers, caregivers, and much more.

If you are interested in submitting an article, contact us at info@phacanada.ca.

Looking for inspiring stories from the PH community? Visit our Your Stories page to read experiences shared by patients, caregivers, and advocates.

Quick Facts: What is Yutrepia?

What it is Yutrepia is a new drug: an inhaled form of treprostinil, a prostacyclin analogue. It was just approved by the Food and Drug...

PHA Canada

1 day ago

Quick facts: Why was the ZENITH sotatercept study stopped?

The ZENITH study looked at some of the sickest pulmonary arterial hypertension (PAH) patients—those labelled as functional class 3...

PHA Canada

7 days ago

There's no health without mental health

"A person's mental health significantly influences how they experience pain and suffering associated with chronic disease. It's essential...

PHA Canada

May 27

What's the Canada Disability Benefit?

We asked Liss Cairns, Program Manager at Plan Institute, some questions about the Disability Tax Credit and the new Canada Disability...

PHA Canada

May 27

Rare But Not Alone: What Canada’s New Drug Strategy Means for People with Pulmonary Arterial Hypertension

Living with a rare disease can feel like walking an unmarked path—isolated, uncertain, and overlooked. For those with pulmonary arterial...

PHA Canada

May 13

New Report Exposes Gaps in BC Medication Coverage

The 2025 BC Medication Coverage Report is here—and it reveals serious gaps in access to life-saving medications across the province....

PHA Canada

Apr 14